Effects of interrater reliability of psychopathologic assessment on power and sample size calculations in clinical trialsMÜLLER, Matthias J; SZEGEDI, Armin.Journal of clinical psychopharmacology. 2002, Vol 22, Num 3, pp 318-325, issn 0271-0749Article

Add-on combination and maintenance treatment: Case series of five obese patients with different Eating behaviorANGHELESCU, Ion; KLAWE, Christoph; SZEGEDI, Armin et al.Journal of clinical psychopharmacology. 2002, Vol 22, Num 5, pp 521-524, issn 0271-0749, 4 p.Article

Mirtazapine compared with paroxetine in major depressionBENKERT, Otto; SZEGEDI, Armin; KOHNEN, Ralf et al.The Journal of clinical psychiatry. 2000, Vol 61, Num 9, pp 656-663, issn 0160-6689Conference Paper

Early improvement as a predictor of acute treatment outcome in manic or mixed episodes in bipolar-1 disorder: A pooled, post hoc analysis from the asenapine development programSZEGEDI, Armin; JUN ZHAO; MCINTYRE, Roger S et al.Journal of affective disorders. 2013, Vol 150, Num 3, pp 745-752, issn 0165-0327, 8 p.Article

Vitamin B12 and hepatic enzyme serum levels correlate in male alcohol-dependent patientsHIMMERICH, Hubertus; ANGHELESCU, Ion; KLAWE, Christoph et al.Alcohol and alcoholism (Oxford). 2001, Vol 36, Num 1, pp 26-28, issn 0735-0414Article

Differentiating moderate and severe depression using the Montgomery-Åsberg depression rating scale (MADRS)MÜLLER, Matthias J; HIMMERICH, Hubertus; KIENZLE, Barbara et al.Journal of affective disorders. 2003, Vol 77, Num 3, pp 255-260, issn 0165-0327, 6 p.Article

Depressive factors and their relationships with other symptom domains in schizophrenia, schizoaffective disorder, and psychotic depressionMÜLLER, Matthias J; SZEGEDI, Armin; WETZEL, Hermann et al.Schizophrenia bulletin. 2001, Vol 27, Num 1, pp 19-28, issn 0586-7614Article

What does the HAMD mean?LEUCHT, Stefan; FENNEMA, Hein; ENGEL, Rolf et al.Journal of affective disorders. 2013, Vol 148, Num 2-3, pp 243-248, issn 0165-0327, 6 p.Article

Long-term effects of asenapine or olanzapine in patients with persistent negative symptoms of schizophrenia: A pooled analysisPOTKIN, Steven G; PHIRI, Phillip; SZEGEDI, Armin et al.Schizophrenia research. 2013, Vol 150, Num 2-3, pp 442-449, issn 0920-9964, 8 p.Article

Meta-Analyses of the Efficacy of Asenapine for Acute Schizophrenia: Comparisons With Placebo and Other AntipsychoticsSZEGEDI, Armin; VERWEIJ, Pierre; DUIJNHOVEN, Wilbert Van et al.The Journal of clinical psychiatry. 2012, Vol 73, Num 12, pp 1533-1540, issn 0160-6689, 8 p.Article

Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depressionSZEGEDI, Armin; MÜLLER, Matthias J; ANGHELESCU, Ion et al.The Journal of clinical psychiatry. 2003, Vol 64, Num 4, pp 413-420, issn 0160-6689, 8 p.Article

Carbohydrate-deficient transferrin (CDT) and HDL cholesterol (HDL) are highly correlated in male alcohol dependent patientsSZEGEDI, Armin; MÜLLER, Matthias J; HIMMERICH, Hubertus et al.Alcoholism, clinical and experimental research. 2000, Vol 24, Num 4, pp 497-500, issn 0145-6008Conference Paper

Asenapine as Adjunctive Treatment for Acute Mania Associated With Bipolar Disorder: Results of a 12-Week Core Study and 40-Week ExtensionSZEGEDI, Armin; CALABRESE, Joseph R; STET, Let et al.Journal of clinical psychopharmacology. 2012, Vol 32, Num 1, pp 46-55, issn 0271-0749, 10 p.Article

A Randomized Placebo-Controlled Trial of Asenapine for the Prevention of Relapse of Schizophrenia After Long-Term TreatmentKANE, John M; MACKLE, Mary; SNOW-ADAMI, Linda et al.The Journal of clinical psychiatry. 2011, Vol 72, Num 3, pp 349-355, issn 0160-6689, 7 p.Article

Distigmine bromide induced acute psychotic disorder in a patient with multiple sclerosisHIMMERICH, Hubertus; SZEGEDI, Armin; KLAWE, Christoph et al.European psychiatry. 2003, Vol 18, Num 6, pp 318-319, issn 0924-9338, 2 p.Article

Is there a common resilience mechanism underlying antidepressant drug response? evidence from 2848 patientsSTASSEN, Hans H; ANGST, Jules; HELL, Daniel et al.The Journal of clinical psychiatry. 2007, Vol 68, Num 8, pp 1195-1205, issn 0160-6689, 11 p.Article

Sequentially adjusted randomization to force balance in controlled trials with unknown prevalence of covariates: Application to alcoholism researchMÜLLER, Matthias J; SCHEURICH, Armin; WETZEL, Hermann et al.Alcohol and alcoholism (Oxford). 2005, Vol 40, Num 2, pp 124-131, issn 0735-0414, 8 p.Article

A Translational Approach to Evaluate the Efficacy and Safety of the Novel AMPA Receptor Positive Allosteric Modulator Org 26576 in Adult Attention-Deficit/ Hyperactivity DisorderADLER, Lenard A; KROON, René A; STEIN, Mark et al.Biological psychiatry (1969). 2012, Vol 72, Num 11, pp 971-977, issn 0006-3223, 7 p.Article

No association between the dopamine D₂ receptor TaqI A1 allele and earlier age of onset of alcohol dependence according to different specified criteriaANGHELESCU, Ion; GERMEYER, Sabine; MÜLLER, Matthias J et al.Alcoholism, clinical and experimental research. 2001, Vol 25, Num 6, pp 805-809, issn 0145-6008Article

Mirtazapine orally disintegrating tablets versus venlafaxine extended release: A double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorderBENKERT, Otto; SZEGEDI, Armin; PHILIPP, Michael et al.Journal of clinical psychopharmacology. 2006, Vol 26, Num 1, pp 75-78, issn 0271-0749, 4 p.Article

Serotonergic polymorphisms in patients suffering from alcoholism, anxiety disorders and narcolepsyFEHR, Christoph; SCHLEICHER, Alexandra; SZEGEDI, Armin et al.Progress in neuro-psychopharmacology & biological psychiatry. 2001, Vol 25, Num 5, pp 965-982, issn 0278-5846Article

Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depressionKEMP, David E; GANOCY, Stephen J; PIKALOV, Andrei et al.Journal of affective disorders. 2011, Vol 130, Num 1-2, pp 171-179, issn 0165-0327, 9 p.Article

Early Improvement in the First 2 Weeks as a Predictor of Treatment Outcome in Patients With Major Depressive Disorder : A Meta-Analysis Including 6562 PatientsSZEGEDI, Armin; JANSEN, Wim T; VAN WILLIGENBURG, Arjen P. P et al.The Journal of clinical psychiatry. 2009, Vol 70, Num 3, pp 344-353, issn 0160-6689, 10 p.Article

The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depressionTADIC, André; MÜLLER, Matthias J; RUJESCU, Dan et al.American journal of medical genetics. Part B, Neuropsychiatric genetics. 2007, Vol 144, Num 3, pp 325-331, issn 1552-4841, 7 p.Article

Systematic Analysis of Glutamatergic Neurotransmission Genes in Alcohol Dependence and Adolescent Risky Drinking BehaviorSCHUMANN, Gunter; JOHANN, Monika; KRAUSE, Kristina et al.Archives of general psychiatry. 2008, Vol 65, Num 7, pp 826-838, issn 0003-990X, 13 p.Article